Deltagen
San Mateo · Founded 1997
About Deltagen
Deltagen, Inc. provides drug discovery tools and services to the biopharmaceutical industry and to the academic research community in the United States. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was founded in 1997 and is headquartered in San Mateo, California.
Company Facts
- Founded: 1997
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.5M
- Funding stage: IPO
- Last round: Series Unknown (Dec 2009)
- Ticker: nasdaq:DGEN
- Website: http://www.deltagen.com
- Phone: (650)345-7601
Industries & Categories
Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/deltagen-839083 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.